EAM
EFG Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,856
| Closed | -$603K | – | 197 |
|
|
2024
Q1 | $603K | Sell |
8,856
-65,422
| -88% | -$4.46M | 0.1% | 187 |
|
|
2023
Q4 | $4.65M | Sell |
74,278
-8,394
| -10% | -$525K | 0.88% | 23 |
|
|
2023
Q3 | $3.75M | Buy |
82,672
+7,687
| +10% | +$349K | 0.89% | 36 |
|
|
2023
Q2 | $4.21M | Sell |
74,985
-20,129
| -21% | -$1.13M | 0.9% | 41 |
|
|
2023
Q1 | $4.3M | Buy |
95,114
+767
| +0.8% | +$34.7K | 0.95% | 37 |
|
|
2022
Q4 | $3.81M | Buy |
94,347
+9,991
| +12% | +$403K | 0.85% | 38 |
|
|
2022
Q3 | $5.52M | Buy |
84,356
+4,456
| +6% | +$291K | 1.27% | 18 |
|
|
2022
Q2 | $4.86M | Buy |
79,900
+3,840
| +5% | +$233K | 1.02% | 32 |
|
|
2022
Q1 | $4.78M | Buy |
+76,060
| New | +$4.78M | 0.72% | 48 |
|